About ZWI Therapeutics
ZWI Therapeutics is a company based in Watertown (United States) founded in 2020. ZWI Therapeutics has raised $10 million across 1 funding round from investors including Co-win Ventures and Sherpa Healthcare Partners. ZWI Therapeutics operates in a competitive market with competitors including Evotec, Crown Bioscience, Alloy Therapeutics, Domainex and NIH, among others.
- Headquarter Watertown, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10 M (USD)
in 1 rounds
-
Latest Funding Round
$10 M (USD), Series A
Jan 25, 2024
-
Investors
Co-win Ventures
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ZWI Therapeutics
ZWI Therapeutics has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ZWI Therapeutics
ZWI Therapeutics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Co-win Ventures and Sherpa Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC fund investing in startups
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for ZWI Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ZWI Therapeutics
Investment portfolio details for ZWI Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ZWI Therapeutics
Detailed financials for ZWI Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zwi Therapeutics Comparisons
Peer comparison for ZWI Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ZWI Therapeutics
ZWI Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Crown Bioscience, Alloy Therapeutics, Domainex and NIH, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery and development services are provided to biopharma sector.
|
|
| Locked | Locked | Locked |
Cancer and CVMD drugs are developed using PDX models.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided for therapeutic development.
|
|
| Locked | Locked | Locked |
Drug discovery CRO company for epigenetic research and inflammatory diseases
|
|
| Locked | Locked | Locked |
Drug discovery services are provided to the biopharma sector.
|
|
| Locked | Locked | Locked |
Drug discovery and development research services are provided.
|
Detailed competitors of ZWI Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zwi Therapeutics
Complete news archive for ZWI Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ZWI Therapeutics
ZWI Therapeutics was founded in 2020 and raised its 1st funding round 4 years after it was founded.
ZWI Therapeutics is headquartered in Watertown, United States.
ZWI Therapeutics is a funded company, having raised a total of $10M across 1 funding round to date.
ZWI Therapeutics was established in 2020 and is based in Watertown, United States. Recruitment services are offered by the company to support talent acquisition for various sectors. Operations are centered on matching candidates with employer needs through structured processes. The domain zwitx.com is maintained for digital outreach and service delivery. Focus is placed on efficient hiring solutions within the recruitment industry.
ZWI Therapeutics's top competitors include Evotec, Crown Bioscience and NIH.
ZWI Therapeutics has 2 investors. Key investors include Co-win Ventures, and Sherpa Healthcare Partners.